These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. VMAT-Mediated changes in quantal size and vesicular volume. Colliver TL; Pyott SJ; Achalabun M; Ewing AG J Neurosci; 2000 Jul; 20(14):5276-82. PubMed ID: 10884311 [TBL] [Abstract][Full Text] [Related]
25. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802 [TBL] [Abstract][Full Text] [Related]
26. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Olivier B; Soudijn W; van Wijngaarden I Prog Drug Res; 2000; 54():59-119. PubMed ID: 10857386 [TBL] [Abstract][Full Text] [Related]
27. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells. Liu Y; Edwards RH J Cell Biol; 1997 Nov; 139(4):907-16. PubMed ID: 9362509 [TBL] [Abstract][Full Text] [Related]
28. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235 [TBL] [Abstract][Full Text] [Related]
29. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. Gu H; Wall SC; Rudnick G J Biol Chem; 1994 Mar; 269(10):7124-30. PubMed ID: 8125921 [TBL] [Abstract][Full Text] [Related]
30. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330 [TBL] [Abstract][Full Text] [Related]
31. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. Kocabas AM; Rudnick G; Kilic F J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070 [TBL] [Abstract][Full Text] [Related]
32. In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters. Chen NH; Reith ME Methods Enzymol; 1998; 296():719-30. PubMed ID: 9779485 [No Abstract] [Full Text] [Related]
33. Loading of oxidizable transmitters into secretory vesicles permits carbon-fiber amperometry. Kim KT; Koh DS; Hille B J Neurosci; 2000 Oct; 20(20):RC101. PubMed ID: 11027252 [TBL] [Abstract][Full Text] [Related]
35. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Erickson JD; Eiden LE; Hoffman BJ Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10993-7. PubMed ID: 1438304 [TBL] [Abstract][Full Text] [Related]
36. Vesicular monoamine transporter 1 is responsible for storage of 5-hydroxytryptamine in rat pinealocytes. Hayashi M; Haga M; Yatsushiro S; Yamamoto A; Moriyama Y J Neurochem; 1999 Dec; 73(6):2538-45. PubMed ID: 10582616 [TBL] [Abstract][Full Text] [Related]